Umehara, Hidehiro
Numata, Shusuke
Watanabe, Shin-ya
Hatakeyama, Yutaka
Kinoshita, Makoto
Tomioka, Yukiko
Nakahara, Kiyoshi
Nikawa, Takeshi
Ohmori, Tetsuro
Article History
Received: 29 December 2016
Accepted: 24 May 2017
First Online: 7 July 2017
Competing Interests
: Dr. Ohmori has received research support or speakers’ honoraria from, or has served as a consultant to, Astellas, Chugai, Daiichi Sankyo, Dainippon Sumitomo, Ehzai, Eli Lilly, Glaxo SmithKline, Janssen, Meiji Seika Pharma, Mochida, MSD, Novartis, Otsuka, Ono, Pfizer, Shionogi, Takeda and Yoshitomi.